These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 17229979)

  • 1. The physiological significance of the alternative pathways of angiotensin II production.
    Kramkowski K; Mogielnicki A; Buczko W
    J Physiol Pharmacol; 2006 Dec; 57(4):529-39. PubMed ID: 17229979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alternative pathways for the activation of the renin-angiotensin system].
    Gurzu B; Costuleanu M; Petrescu G
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):710-7. PubMed ID: 14756007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The importance of ACE2 in regulating the cardiovascular system].
    Raz A; Gamliel-Lazarovich A; Bogner I; Strigevsky A; Keidar S
    Harefuah; 2007 Sep; 146(9):703-6, 733. PubMed ID: 17969309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE inhibition in the tissues.
    Unger T; Gohlke P
    Clin Physiol Biochem; 1992; 9(3):89-93. PubMed ID: 1338777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-angiotensin system: importance in physiology and pathology.
    Ferrario CM
    J Cardiovasc Pharmacol; 1990; 15 Suppl 3():S1-5. PubMed ID: 1691411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.
    Urata H; Ganten D
    Eur Heart J; 1993 Nov; 14 Suppl I():177-82. PubMed ID: 8293772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
    Waeber B; Nussberger J; Juillerat L; Brunner HR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension.
    Sadjadi J; Kramer GL; Yu CH; Burress Welborn M; Chappell MC; Gregory Modrall J
    J Surg Res; 2005 Aug; 127(2):65-9. PubMed ID: 15869764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Active metabolites derived from angiotensin II].
    Chansel D; Ardaillou R
    Nephrologie; 1998; 19(7):427-32. PubMed ID: 9857379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
    Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin I converting enzyme and chymase in cardiovascular tissues.
    Nishimura H; Hoffmann S; Baltatu O; Sugimura K; Ganten D; Urata H
    Kidney Int Suppl; 1996 Jun; 55():S18-23. PubMed ID: 8743505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging concepts about the renin angiotensin system: present and future clinical applications.
    McLigeyo SO
    East Afr Med J; 1996 Sep; 73(9):607-10. PubMed ID: 8991244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A scrutiny of the biochemical pathways from Ang II to Ang-(3-4) in renal basolateral membranes.
    Axelband F; Dias J; Miranda F; Ferrão FM; Barros NM; Carmona AK; Lara LS; Vieyra A
    Regul Pept; 2009 Nov; 158(1-3):47-56. PubMed ID: 19703499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiological roles of human chymase].
    Nakayama S; Urata H; Arakawa K
    Nihon Rinsho; 1997 Aug; 55(8):1903-8. PubMed ID: 9284400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells.
    Lavrentyev EN; Estes AM; Malik KU
    Circ Res; 2007 Aug; 101(5):455-64. PubMed ID: 17626897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating versus local angiotensin II in blood pressure control: lessons from tissue-specific expression of angiotensin-converting enzyme (ACE).
    Xiao HD; Fuchs S; Frenzel K; Teng L; Bernstein KE
    Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):137-45. PubMed ID: 15104531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative pathways for angiotensin II generation in the cardiovascular system.
    Becari C; Oliveira EB; Salgado MC
    Braz J Med Biol Res; 2011 Sep; 44(9):914-9. PubMed ID: 21956534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of cardiac renin-angiotensin system in swimming induced physiological myocardial hypertrophy].
    Tian B; Gao GD; Liu J; Cao ZP; Lu X
    Sheng Li Xue Bao; 1994 Oct; 46(5):509-13. PubMed ID: 7846553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.